Our office utilizes OralID during our Oral Exam for Oral Cancer Screenings. Study results have shown that a COE (Clinical Oral Examination) alone may not detect and discriminate reliability between benign, dysplastic lesions and OSCC (oral squamous cell carcinoma). Some mucosal, dysplastic, or even early stage cancer lesions may manifest in mucosa that appears to be normal clincailly.
When found at an early stage of development (Stage I and II), oral cancers have an 80 to 90 percent survival rate. The problem is that the majority of oral cancers are found in late stages (Stage II and IV), resulting in a mortality rate of 43 percent at a five-year diagnosis (for all stages combined).
Did you know that…
40 percent of oral cancers are found in patients who do not present with any of the traditional risk factors or any other significant lifestyle risks?
The traditional risk factors of oral cancer include:
Previous history of oral cancer
Over 40 years of age
This means all patients, regardless of age and lifestyle, need an oral exam that looks closely for abnormal tissue.
OralID uses a proven, optically based technology called “fluorescence technology.” OralID’s fluorescence technology uses a blue light (435–460 nm) that allows a clinician to identify oral cancer, pre-cancer and other abnormal lesions at an earlier stage, thus saving lives. The medical applications of fluorescence technology includes diagnosis of the GI tract, cervix, lung, skin and oral mucosa.